Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Canine probiotic Bifidobacteria globosum

a probiotic and lactic acid bacteria technology, applied in the field of probiotic microorganisms, can solve the problems of high complexity of defense mechanisms to protect the gastrointestinal tract of mammals from colonisation by pathogenic bacteria, promote inflammation and aberrant immune responses, and promote inflammation and aberration of immune responses. , to achieve the effect of improving pet health

Inactive Publication Date: 2005-07-14
IAMS +1
View PDF60 Cites 76 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0011] Furthermore, the present invention is directed towards providing uses of Bifidobacteria globosum bacteria obtainable by isolation from resected and washed canine gastrointestinal tract for maintaining and improving pet health, and compositions comprising the lactic acid bacteria.

Problems solved by technology

The defense mechanisms to protect the mammalian gastrointestinal (GI) tract from colonisation by pathogenic bacteria are highly complex.
These factors disrupt the intestinal microflora equilibrium and can promote inflammation and aberrant immune responses.
However, these bacteria were obtained from faecal samples, and may not form part of the natural intestinal microflora present in the upper portion of the GI tract.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Canine probiotic Bifidobacteria globosum
  • Canine probiotic Bifidobacteria globosum
  • Canine probiotic Bifidobacteria globosum

Examples

Experimental program
Comparison scheme
Effect test

example 1

Isolation of Bifidobacteria globosum Bacteria from Canine GI Tracts

[0089] Canine intestinal samples were obtained from healthy dogs presenting at the local veterinarians for owner initiated and approved euthanasia. All animals were healthy and disease-free. The colon, mid-colon, caecum and ileum of each dog were dissected in order to expose the mucosa.

[0090] Supernatants were removed following agitation of the mucosal tissue (vortexed for 1 minute) and following mechanical homogenisation of the tissue. Each supernatant was plated on Reinforced Clostridia Agar (RCA) or MRS plus 0.05% cysteine plus mupirocin. These were incubated anaerobically, using the Anerocult GasPak system, for 24 hours at 37° C. Isolated colonies from the plates were re-streaked onto either MRS or RCA and again grown anaerobically under the same conditions. Isolated colonies were re-streaked a further 4 times in order to purify a single strain. Colony morphology and microscopic appearance were assessed. Suitab...

example 2

Screening for Anti-Microbial Activity

[0092] The isolated Bifidobacteria globosum bacterial strains were incubated anaerobically in TPY broth. 2□1 of each culture were spotted onto TPY agar plates and incubated anaerobically overnight. Salmonella typhimurium, Listeria monocytogenes, Listeria innocua and Eschericia coli 0157H45 were pre-grown overnight and 100 μl inoculated into molten agar (1% v / v). This indicator culture was poured onto the surface of the inoculated MRS or TPY plates. Following overnight incubation, zones of inhibition around the probiotic colony were measured. All experiments were performed in duplicate on three separate occasions. In addition, incorporating the buffer 2% betaglycerophosphate into the agar enabled assessment of the contribution of acid production to the observed pathogen inhibition in vitro.

[0093] The data presented in FIGS. 1, 2, 3 and 4 clearly demonstrate that the Bifidobacteria globosum bacteria strains of the present invention obtainable by ...

example 3

In Vitro Measures of Survival and Colonisation

pH Tolerance

[0094] Bacterial cells were harvested from overnight cultures, washed twice in phosphate buffer (pH 6.5) and resuspended in TPY broth adjusted with 1M HCl to pH 2.5. The cells were incubated anaerobically at 37° C. and their survival measured at intervals of 0, 30, 60, 120, 240 and 360 minutes using the plate count method known to those skilled in the art.

[0095]FIG. 5 clearly demonstrates that five strains were resistant to pH 2.5 over 1 hour. Table 2 summarises this data per strain.

TABLE 2StrainConc. After 1designationStarting Conc.hourViability (%)AHC A1.50E+081.20E+0880AHC B4.00E+075.50E+07137AHC C1.10E+081.50E+08136AHC F6.00E+086.00E+08100AHC 72.50E+074.50E+07180

Bile Resistance

[0096] The bacterial strains were streaked onto TPY agar supplemented with porcine bile (Sigma) at 0.5%, 1% and 5% (w / v). Plates were incubated at 37° C. under anaerobic conditions and the growth recorded after 24 hours. Growth was compared ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
pHaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.

Description

CROSS REFERENCE TO RELATED APPLICATION [0001] This Application claims the benefit of U.S. Provisional Application No. 60 / 531,588 filed on Dec. 19, 2003.FIELD OF THE INVENTION [0002] The present invention relates to the field of probiotic micro-organisms, more specifically canine probiotic lactic acid bacteria and methods of use. BACKGROUND OF THE INVENTION [0003] The defense mechanisms to protect the mammalian gastrointestinal (GI) tract from colonisation by pathogenic bacteria are highly complex. The GI tract of most mammals are colonised by native microflora, and invasive pathogenic micro-organisms. In a healthy individual, these competing microflora are in a state of equilibrium. Modification of the intestinal microflora equilibrium may lead to or prevent many GI disorders, both in humans, and other mammalian species, such as companion animals including cats, dogs and rabbits. The well being of companion animals is closely related to their feeding and GI health, and maintenance o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A23K1/00A23K1/18A61K35/745A61K45/00C12N1/20C12R1/01
CPCA23K1/008A23K1/009A23K1/1846A23K1/1853C12R1/01A23K1/1866A23L1/3014A61K35/745C12N1/20A23K1/186A23K10/16A23K10/18A23K50/40A23K50/42A23K50/45A23K50/48A23L33/135A61P1/00A61P1/12A61P13/00A61P17/00A61P31/00A61P31/04A61P37/00A61P37/02C12R2001/01C12N1/205
Inventor BOILEAU, THOMASCEDDIA, MICHAELCOLLINS, JOHNDAVENPORT, GARYKIELY, BARRYO'MAHONY, LIAMSUNVOLD, GREGORYTETRICK, MARKVICKERS, ROBERT
Owner IAMS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com